In test, nasal spray prevents replication of the coronavirus by 96%

0
6


The drug was able to prevent replication of the virus that caused covid-19, but more tests are lacking

A nasal spray made with the compound called INNA-051 managed to stop the replication of the coronavirus 96% in laboratory tests. The substance was created to contain the spread of the common flu virus and colds, but has not yet been proven effective for that purpose.

INNA-051 was developed by the Australian Ena Respiratory and has molecules that activate the TLR2 and TLR6 receptors in the cells of the nose and throat. As a result, there is an increase in immunity in these regions.

Subscribe and have the best content of your day, perhaps the only one you need.

digital exam

R $ 15.90 / month

  • Access wherever and whenever you want.
  • Unlimited access to exclusive content on macroeconomics, markets, careers, entrepreneurship, technology and finance.

digital + printed exam

R $ 44.90 / month

  • Access wherever and whenever you want
  • Unlimited access to exclusive content on macroeconomics, markets, careers, entrepreneurship, technology and finance.
  • Biweekly print edition.
  • Free shipping

3967494

LEAVE A REPLY

Please enter your comment!
Please enter your name here